JEFFREY COBB: Open Payments
NPI 1376028167 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,315 in 142 payments from 21 companies in 2025. Trend: 2023 $1,778 · 2024 $1,978 · 2025 $2,315
Food & beverage: $2,315
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $462 |
| GENZYME CORPORATION | 7 | $272 |
| Janssen Biotech, Inc. | 29 | $263 |
| Ardelyx, Inc. | 12 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $180 |
| Aimmune Therapeutics, Inc. | 23 | $170 |
| Lilly USA, LLC | 5 | $162 |
| Madrigal Pharmaceuticals | 6 | $107 |
| QOL Medical, LLC | 4 | $102 |
| Gilead Sciences, Inc. | 5 | $95 |
Products named: DUPIXENT, TREMFYA, IBSRELA, RINVOQ, ENTYVIO, OMVOH, VOWST, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
